Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions

Asthma

Interventions

DRUG

indacaterol maleate

Trial Locations (5)

North Carolina Clinical Research, Raleigh

Clinical Research Institute, Minneapolis

The Clinical Research Center, St Louis

Colorado Allergy and Asthma Centres, P.C., Denver

Northeast Medical Research Associates, Inc., North Dartmouth